Riskpilot← Back to searchSign inGet full accessMELODENT MYSEN AS
ASActiveOrg 989157132Søndre Mysens Vei 2E, 1850 MysenDental practice care activities · NACE 8623Est. 20061 employees
Revenue 2024
NOK 4,1M
+18% vs 2023
EBITDA margin
10.9%
+574% vs 2023
Equity ratio
83.1%
Financial strength
Net profit 2024
NOK 321K
+278% vs 2023
| Revenue | NOK 4,1M | +18% |
| EBITDA | NOK 452K | +574% |
| Net profit | NOK 321K | +278% |
| Total assets | NOK 856K | +54% |
| Equity | NOK 711K | +82% |
| Employees | 1 | — |
Legal name
MELODENT MYSEN AS
Org number
989157132
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
26. januar 2006
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Bedrive tannhelsetjenester, samt det som naturlig står i forbindelse med dette, herunder delta i andre selskaper med lignende virksomhet.
Address
Søndre Mysens Vei 2E, 1850 Mysen
Phone
+4769892750
Email
post@tannlegerinorge.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 136 | 2 901 | 3 018 | 3 516 | 4 142 |
| Staff expenses | −1 277 | −1 277 | −1 024 | −537 | −15 |
| EBITDA | 719 | 345 | 425 | −95 | 452 |
| Depreciation & amort. | −54 | −87 | −78 | −86 | −55 |
| EBIT | 665 | 258 | 347 | −181 | 397 |
| Net financials | 2 | 1 | 2 | 1 | 6 |
| Profit before tax | 666 | 259 | 349 | −180 | 403 |
| Tax | 148 | 56 | 75 | −0 | 82 |
| Net profit | 518 | 203 | 274 | −180 | 321 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 965 | 662 | 632 | 555 | 856 |
| Equity | 620 | 442 | 417 | 390 | 711 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 345 | 220 | 216 | 165 | 145 |
| Total debt | 345 | 220 | 216 | 165 | 145 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20202024
Equity ratio
83.1%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
45.1%
This company
18.4%
Market median
+145% vs market
20202024
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20202024
Asset turnover
4.84×
This company
1.12×
Market median
+332% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LL Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
RG Deputy Member | Deputy Member | 2006 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2006 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MELODENT MYSEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnar Gjerløw Eriksen | Deputy Member | 0 companies |
| Louise Linn Lam | Chief Executive Officer | 0 companies |
| Grete Gangnæs | Chairman | 0 companies |
| Mehmet Süslü | Chairman | 0 companies |